Free Trial
→ The Trump Dump is starting; Get out of stocks now? (From Paradigm Press) (Ad)

3 High-Growth Stocks Traders Love and Investors Should Watch

Chris Markoch
Written by Chris Markoch | Reviewed by Shannon Tokheim
June 5, 2025

Key Points

  • TransMedics Group is a leader in organ transplant logistics, drawing interest from traders and long-term investors.
  • SMR stock is up 78% this year, fueled by DoE contracts and rising demand for nuclear energy as AI drives power needs higher.
  • DAVE stock has soared over 120% in 2025 and 2,600% since 2023, driven by its fintech solutions that appeal to underserved banking customers.
  • Five stocks to consider instead of NuScale Power.

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

Already have an account? Log in here.

Should You Invest $1,000 in NuScale Power Right Now?

Before you consider NuScale Power, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NuScale Power wasn't on the list.

While NuScale Power currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Chris Markoch
About The Editor

Chris Markoch

Editor & Contributing Author

Value Investing, Retirement, Dividend Stocks, Individual Investing

Learn More about Chris Markoch
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
TransMedics Group (TMDX)
1.3277 of 5 stars		$130.22+1.3%N/A95.75Moderate Buy$127.33
NVIDIA (NVDA)
4.8824 of 5 stars		$155.12+0.5%0.03%50.04Moderate Buy$175.78
Dave (DAVE)
3.1098 of 5 stars		$243.32+7.6%N/A67.03Moderate Buy$212.33
NuScale Power (SMR)
1.7357 of 5 stars		$38.29-1.0%N/A-27.95Moderate Buy$29.38
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Congress Bought This Stock at the Bottom—Will You Miss It?
June 20, 2025

Congress Bought This Stock at the Bottom—Will You Miss It?

MarketBeat’s Thomas Hughes breaks down the biggest congressional moves, which are stocks seeing renewed interest and how retail investors can benefit.

Watch Video

Related Videos

Why AMD Stock Beats NVIDIA Right Now
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines